SCYX - SCYNEXIS ALERT: Bragar Eagel & Squire P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against SCYNEXIS Inc. and Encourages Investors to Contact the Firm | Benzinga
NEW YORK, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against SCYNEXIS, Inc. ("SCYNEXIS" or the "Company") (NASDAQ:SCYX) in the United States District Court for the District of New Jersey on behalf of all persons and entities who purchased or otherwise acquired SCYNEXIS securities between March 31, 2023 and September 22, 2023, both dates inclusive (the "Class Period"). Investors have until January 8, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
Click here to participate in the action.
On September 25, 2023, before the market opened, the Company reported that, following a recent review of the manufacturing process and equipment at the vendor that manufactures the ibrexafungerp drug substance, the Company became aware of potential cross contamination of ibrexafungerp with a non-antibacterial beta-lactam drug substance. As the Company explained, "[c]urrent FDA guidance recommends segregating the manufacture of beta-lactam compounds from other compounds since beta-lactam compounds have the potential to ...